Genetic Signatures Ltd. · ASX:GSS
Genetic Signatures — Q4 2025 Earnings Presentation
20 slides from Genetic Signatures's earnings presentation, Aug 24, 2025
Slide 1: FY25 Market Update
al use only FY25 Market Update 25 August 2025
Slide 2: FY25 Market Update
FY25 Market Update al use only 2
Slide 3: al use only
FY25 Market Update al use only • • • 3
Slide 4: al use only
FY25 Market Update • • al use only • • • • • • 4
Slide 5: FY25 Result
al use only FY25 Result 25 August 2025 5
Slide 6: al use only
FY25 Market Update • • • al use only 6
Slide 7: al use only
FY25 Market Update • • al use only • • • 7
Slide 8: al use only
FY25 Market Update • al use only • • • Note: Term deposits treated as a financial asset for accounting purposes at 30 June 2025 but included as cash for illustrative purposes. 8
Slide 9: Operational Update
al use only Operational Update 25 August 2025 9
Slide 10: al use only
FY25 Market Update al use only • • • • • 10
Slide 11: al use only
FY25 Market Update • al use only • • 11
Slide 12: al use only
FY25 Market Update • al use only • • 12
Slide 13: al use only
FY25 Market Update al use only • • • • 13
Slide 14: al use only
FY25 Market Update • al use only • • 14
Slide 15: al use only
FY25 Market Update • al use only • • • 15
Slide 16: al use only
FY25 Market Update • al use only • • • • 16
Slide 17: al use only
FY25 Market Update al use only • • • 17
Slide 18: al use only
FY25 Market Update al use only 18
Slide 19: al use only
FY25 Market Update • al use only • • • • 19
Slide 20: Contact Us
Contact Us Allison Rossiter al use only Chief Executive Officer E: allison.rossiter@geneticsignatures.com P: +61 (02) 9870 7580 Karl Pechmann Chief Financial & Operating Officer & Joint Company Secretary E: karl.pechmann@geneticsignatures.com Visit us www.geneticsignatures.com Follow us 20